$-0.04
(Market cap
$914 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
5.6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.4 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-2.1
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-2.1
-
Face value
--
-
Shares outstanding
62,845,812
10 Years Aggregate
CFO
$-963.47 Mln
EBITDA
$-1,132.99 Mln
Net Profit
$-1,164.09 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
DBV Technologies S.A. - ADR
| -24.5 | 6.2 | -20.3 | 51.3 | -0.9 | -21.8 | -27.2 |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
DBV Technologies S.A. - ADR
| 520.4 | -67.3 | -37.7 | -4.4 | -38.9 | -75.5 | 66.7 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
DBV Technologies S.A. - ADR
|
14.5 | 914.4 | 0.0 | -175.9 | -- | -106.8 | -- | 5.6 |
| 3.6 | 342.9 | 56.6 | -65.4 | -121.7 | -111.8 | -- | 8.4 | |
| 12.4 | 2,195.3 | 549.1 | 17.9 | -6.3 | 1.4 | 126.3 | 1.7 | |
| 6.1 | 77.2 | 5.3 | -7.9 | -142.5 | -155.3 | -- | 11.7 | |
| 11.8 | 838.7 | 366.5 | 9.3 | 8.3 | 3.4 | 84.6 | 3.1 | |
| 3.6 | 614.9 | 4.1 | -187.9 | -4,613.1 | -233.9 | -- | 0.3 | |
| 14.0 | 130.1 | 0.0 | -42.2 | -- | -- | -- | 2.6 | |
| 13.5 | 824.8 | 0.6 | -59.9 | -9,892.6 | -118.9 | -- | 21.3 | |
| 6.6 | 660.0 | 143.5 | -158.2 | -80.2 | -168.9 | -- | 6.9 | |
| 26.8 | 2,920.0 | 449.6 | -188.2 | -41.1 | -28.5 | -- | 4.8 |
Shareholding Pattern
View DetailsAbout DBV Technologies S.A. - ADR
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed... Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France. Read more
-
CEO & Director
Mr. Daniel Tassé
-
CEO & Director
Mr. Daniel Tassé
-
Headquarters
Châtillon
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for DBV Technologies S.A. - ADR
What is the current share price of DBV Technologies SA - ADR Today?
The share price of DBV Technologies SA - ADR is $14.48 (NASDAQ) as of 27-Aug-2026 16:00 EDT. DBV Technologies SA - ADR has given a return of -0.95% in the last 3 years.
What is the current PB & PE ratio of DBV Technologies SA - ADR?
Since, TTM earnings of DBV Technologies SA - ADR is negative, P/E ratio is not available.
The P/B ratio of DBV Technologies SA - ADR is 5.59 times as on 21-Aug-2026, a 16 premium to its peers’ median range of 4.82 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-9.99 |
8.70 |
2024 |
-0.52 |
2.17 |
2023 |
-1.26 |
0.65 |
2022 |
-1.49 |
0.74 |
2021 |
-0.90 |
0.89 |
What is the 52 Week High and Low of DBV Technologies SA - ADR?
The 52-week high and low of DBV Technologies SA - ADR are Rs 26.19 and Rs 8.70 as of 28-Aug-2026.
What is the market cap of DBV Technologies SA - ADR?
DBV Technologies SA - ADR has a market capitalisation of $ 914 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in DBV Technologies SA - ADR?
Before investing in DBV Technologies SA - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.